Last updated on August 2019

Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors


Brief description of study

The purpose of this study is to assess the safety and tolerability of BMS-663513 in subjects with advanced and/or metastatic malignant tumors.

Clinical Study Identifier: NCT02534506

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.